拦截牛皮-牛皮关节炎连续:为危险,亚临床和早期牛皮关节炎准确医学框架
Francesco Caso1, Mario Cascone2, Nicolò Girolimetto3
1Rheumatology Research Section, Department of Clinical Medicine and Surgery, University of Naples Federico II; and ImmunoPharmaLab, Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Clinical and experimental rheumatology
|January 9, 2026
概括
早期发现牛皮关节炎 (PsA) 是非常重要的. 研究表明,整合遗传分析,查,成像和干预措施可以帮助预防牛皮患者的关节损伤.
科学领域:
- 风湿病学和免疫学
- 皮肤病学 皮肤病学
- 精准医学是一门精准的医学.
背景情况:
- 牛皮关节炎 (PsA) 影响20-30%的牛皮 (PsO) 患者,通常是在静默的炎症阶段之后.
- 由于缺乏分期标准,生物标志物和监测方法,PsA风险的早期识别受到限制.
- 这种差距阻碍了及时干预,以防止不可逆转的关节损伤.
研究的目的:
- 审查关于从牛皮到牛皮性关节炎的过渡现有知识.
- 探索早期检测和干预风险人群的潜在策略.
- 为了支持预防PsA的精准医学方法.
主要方法:
- 结构化叙事审查PubMed文献到2025年6月.
- 专注于免疫遗传驱动因素,分期框架,风险模型,成像和PsA拦截的干预措施.
- 综合了有关风险因素和早期检测模式的研究结果.
主要成果:
- PsA风险分层利用了诸如PsO严重程度,指甲疾病,家族病史,肥胖和炎症的临床/成像发现等因素.
- 先进的成像 (超声波,MRI) 可以检测PsO患者的亚临床炎症.
- 早期的生物DMARDs可能会延迟PsA发作,但随机试验的证据缺乏;生活方式干预表明有希望但需要测试.
结论:
- 一个阶段性连续模型的PsA,整合遗传特征,查,成像,和有针对性的干预措施,与精确医学一致.
- 基于生物标志物的前性试验对于验证预测算法至关重要.
- 需要综合性皮肤病理-风湿病理护理途径,以有效预防和早期治疗PsA.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
346
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
346
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
455
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
455
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


